Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study

Patients with cervical dystonia (CD) require regular injections of botulinum neurotoxin type A (BoNT-A) to maintain treatment effectiveness. In this secondary analysis of a large routine-practice study, we assessed the response to abobotulinumtoxinA over repeated cycles and compared the responses of patients previously na ïve to BoNT treatment to those already treated with BoNT-A.

Source: Journal of the Neurological Sciences - July 8, 2020 Category: Neurology Authors: Carlo Colosimo, David Charles, Vijay P. Misra, Pascal Maisonobe, Savary Om, INTEREST IN CD2 study group Source Type: research